在双极性抑郁症中治疗 ketamine 治疗的无情症
Alina Wilkowska1, Mariusz S Wiglusz1, Aleksandra Arciszewska-Leszczuk2
1Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
Bipolar disorders
|February 4, 2024
概括
在最近的一项研究中,胺有效地降低了双极性抑郁症的关键症状 - - 安赫多尼亚. 这种治疗也改善了焦虑症状,为耐治疗病例提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 双极性抑郁症显著影响患者的生活质量和职业功能.
- 无情,一个核心症状,与治疗耐药性,自杀倾向和不良结果有关.
- 目前对双极性抑郁症中无情症的治疗方法有限,这凸显了未满足的临床需求.
研究的目的:
- 为了评估添加胺的疗效治疗治疗耐治疗双极性抑郁症患者的无情.
- 评估胺对患者报告和临床医生评估的无症措施的影响.
- 检查对情绪/认知,焦虑/身体症状和睡眠的二次影响.
主要方法:
- 采用了一个开放的标签,自然主义的研究设计.
- 患者接受了胺注射,在基线评估,在治疗期间 (第三,第5,第7注射) 和治疗后1周.
- 使用斯奈思-汉密尔顿快乐度量和蒙哥马利-阿斯伯格抑郁症评级度量安赫多尼亚子度量进行了测量.
主要成果:
- 通过患者报告和基于评价者的评估,观察到无情感的显著改善.
- 抑郁症症状自查报告 (IDS-SR) 显示,焦虑/身体和情绪/认知领域的最突出的改善.
- 在睡眠领域没有明显的改善,也没有报告严重的不良事件.
结论:
- 添加胺证明了作为治疗耐治疗双极性抑郁症中无情症的治疗潜力.
- 胺也有效地减少了这种患者群体中的焦虑症状.
- 进一步的研究是有必要的,以探索胺在治疗抗性双极性抑郁症中的作用,考虑到无情感和焦虑的重大影响.
更多相关视频
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
31.4K
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
相关概念视频
01:24Mania and Antimanic Drugs: Overview
181
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
181
01:23Antidepressant Drugs: MAOIs and Other Agents
234
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234
01:30Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
01:24Parenteral Anesthetics: Overview
127
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
127
01:28Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
176
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
176